Article
Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.
Clinical immunology (Orlando, Fla.) - 1 Oct 2017
Hanley Patrick, Sutter Jennifer A, Goodman Noah G, Du Yangzhu, Sekiguchi Debora R, Meng Wenzhao, Rickels Michael R, Naji Ali, Luning Prak Eline T
Abstract excerpt
Although autoantibodies have been used for decades as diagnostic and prognostic markers in type 1 diabetes (T1D), further analysis of developmental abnormalities in B cells could reveal tolerance checkpoint defects that could improve individualized therapy. To evaluate B cell developmental progression in T1D, immunophenotyping was used to classify circulating B cells into transitional, mature naïve, mature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
